08.03.2014 Views

The neurotoxic cascade in the ischemic penumbra

The neurotoxic cascade in the ischemic penumbra

The neurotoxic cascade in the ischemic penumbra

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Radiopharmacie, Service de Médec<strong>in</strong>e Nucléaire,<br />

In vivo imag<strong>in</strong>g of experimental stroke :<br />

animal models, PET and SPECT radiotracers<br />

Part 1 : animal models of stroke<br />

Part 2 : major processes and mediators <strong>in</strong>volved <strong>in</strong> stroke<br />

PET and SPECT imag<strong>in</strong>g of stroke<br />

P. PISANO, PU/PH<br />

B. GUILLET, MCU, Assistant


valence and classification of acute strokes<br />

Third lead<strong>in</strong>g cause of death<br />

Lead<strong>in</strong>g cause of permanent disability<br />

No <strong>in</strong> vitro methods<br />

Acute stroke<br />

Hemorrhagic stroke<br />

Ischemic stroke 85%<br />

arachnoïd<br />

morrhage<br />

(SAH)<br />

Intra-cerebral<br />

Hemorrhage<br />

(ICH)<br />

Extra-cranial<br />

embolism<br />

Intra-cran<br />

thrombos


w to reproduce human thromboembolic stroke?


al of experimental <strong>ischemic</strong> stroke<br />

reduction of cerebral blood flow (CBF)<br />

reduction of oxygen and glucose supply<br />

to bra<strong>in</strong> tissue<br />

Size <strong>in</strong>farction predicted by<br />

<strong>in</strong>tensity<br />

duration<br />

of <strong>the</strong> CBF reduction<br />

100 %<br />

CBF Flow<br />

50 %<br />

25 %<br />

probability for <strong>in</strong>farction < 5%<br />

probability for <strong>in</strong>farction > 95%


BF reduction <strong>in</strong> focal <strong>ischemic</strong> strokes<br />

cal ischemia = reduction <strong>in</strong> blood flow to a very dist<strong>in</strong>ct specific bra<strong>in</strong> regio<br />

No blood flow<br />

<strong>the</strong> very central core of<br />

<strong>the</strong> ischemia,<br />

ut collateral circulation)<br />

from D<strong>in</strong>argl, 1999,<br />

Gradient of blood flow from <strong>the</strong> <strong>in</strong>ner core<br />

reach<strong>in</strong>g out to <strong>the</strong> limits of <strong>the</strong> <strong>ischemic</strong> area :


cal <strong>ischemic</strong> stroke by MCAO<br />

Willis circle :<br />

carotid and vertebrobasilar<br />

arterial system connected<br />

Occlusion of one of <strong>the</strong> major cerebral<br />

blood vessel middle cerebral artery (MCA<br />

X<br />

Proximal<br />

Distal<br />

X X


nes<strong>the</strong>sia Protocol and Monitor<strong>in</strong>g<br />

Anes<strong>the</strong>sia:<br />

<strong>in</strong>tubation and mechanical ventilation<br />

sevoflurane 1.2 MAC<br />

blood arterial pressure<br />

Monitor<strong>in</strong>g:<br />

temperature<br />

sevoflurane, O 2 et CO 2<br />

blood gases<br />

glycemiae<br />

Measurement and control of physiological parameters so that<br />

<strong>in</strong>farction size or cell <strong>in</strong>jury can be reproducible and consistent.


urgical protocol without craniotomy<br />

1h MCAO<br />

reperfusio<br />

A. Cérébrale<br />

Moyenne<br />

A. Ptérygo-Pallat<strong>in</strong>e<br />

A. Carotide Externe<br />

A. Carotide <strong>in</strong>terne<br />

A. Carotide Commune


utcome measurement of <strong>in</strong>jury<br />

eurological score (Longa et al., 1989).<br />

Neurobehavioral assessment<br />

S1<br />

otarod<br />

S2<br />

0<br />

1<br />

2<br />

3<br />

4<br />

no neurolocal deficit<br />

forelimb flexion<br />

unilateral circl<strong>in</strong>g<br />

sw<strong>in</strong>g<strong>in</strong>g of <strong>the</strong> body on <strong>the</strong> left side<br />

motionless<br />

Bra<strong>in</strong> <strong>in</strong>farct volume calculation<br />

mild deficit<br />

moderate deficit<br />

severe deficit<br />

unconciousness<br />

Swanson et al. JCBFM 1990<br />

h= <strong>in</strong>ter-slice<br />

distance


markers <strong>in</strong>itially developed to explore : - tumor hypoxia<br />

- myocardial<br />

ischemia<br />

Part 2 : <strong>neurotoxic</strong> <strong>cascade</strong> of<br />

ischemia<br />

PET and SPECT imag<strong>in</strong>g of <strong>penumbra</strong>


<strong>neurotoxic</strong> <strong>cascade</strong> <strong>in</strong> <strong>the</strong> <strong>ischemic</strong> <strong>penumbra</strong><br />

De Keyser et al., 1999<br />

15<br />

-O, 18 FDG, 18 F-MISO,<br />

11<br />

C-FMZ, 18F-CPFPX<br />

PLA2<br />

BBB disruption, endo<strong>the</strong>lial disturbances<br />

Cell <strong>in</strong>filtration<br />

Cell necrosis<br />

Tissue remodel<strong>in</strong>g, angiogenesis,


T imag<strong>in</strong>g of reduced CBF Phelps, Mol. Imag<strong>in</strong>g, 2004<br />

Initially, limited exclusively to <strong>the</strong> determ<strong>in</strong>ation of :<br />

Cerebral blood flow (CBF, 15O-H2O)<br />

Oxygen extraction fraction (15O-O2)<br />

Glucose metabolism (18FDG)<br />

In <strong>penumbra</strong>, oxygen extraction fraction (OEF) is <strong>in</strong>creased and neurons<br />

are functionally disturbed but still viable


ET imag<strong>in</strong>g of hypoxic cells with nitroimidazoles<br />

18F-fluoromisonidazole (18FMISO)<br />

FMISO<br />

Nitroréductase<br />

Radical anion<br />

Normoxia<br />

Diffuses<br />

Hypoxia<br />

Irreversibly bound to


ET imag<strong>in</strong>g of hypoxic cells<br />

Read et al., Neurology. 19<br />

18<br />

F-fluoromisonidazole (18FMISO) <strong>in</strong> humans<br />

22h post-<strong>in</strong>farct<br />

10d post-<strong>in</strong>farct<br />

MISO b<strong>in</strong>d<strong>in</strong>g is <strong>in</strong>dicative of :<br />

f<strong>in</strong>al CT <strong>in</strong>farct area<br />

- ongo<strong>in</strong>g tissue hypoxia<br />

- not merely recent tissue <strong>in</strong>ju


ET imag<strong>in</strong>g of hypoxic cells<br />

Ito et al., Acad Radiol 200<br />

68<br />

Ga-labeled metronidazole <strong>in</strong> a breast tumor-bear<strong>in</strong>g r


PECT imag<strong>in</strong>g of hypoxic cells<br />

Song et al., (Stroke 2003)<br />

99m<br />

Tc-metronidazole <strong>in</strong> patients with <strong>ischemic</strong> stroke<br />

EC-MN<br />

99m<br />

Tc-Neurolite®<br />

99m<br />

Tc-EC-MN


T imag<strong>in</strong>g of hypoxic cells by down-regulated receptors<br />

11<br />

C-flumazenil <strong>in</strong> cats<br />

Heiss et al., Stroke 19<br />

C I 1h 4h<br />

Defect <strong>in</strong> FMZ b<strong>in</strong>d<strong>in</strong>g predicts <strong>the</strong> size of <strong>the</strong> f<strong>in</strong>al <strong>in</strong>farct whereas


T imag<strong>in</strong>g of hypoxic cells by down-regulated receptors<br />

adenos<strong>in</strong>e A(1) receptors<br />

Tadashi et al., J Nucl Med 20<br />

• [1-methyl-( 11 )C]8-dicyclopropylmethyl-1-methyl-3-propylxanth<strong>in</strong>e (MPD<br />

•<br />

18<br />

F-CPFPX (8-cyclopentyl-3-(3 fluoropropyl)-1-propylxanth<strong>in</strong>e)<br />

-CPFPX<br />

Degree of decrease<br />

<strong>in</strong> A1R ligand b<strong>in</strong>d<strong>in</strong>g is a sensitive<br />

predictor of severe <strong>ischemic</strong> <strong>in</strong>sult<br />

Transient MCAO <strong>in</strong> cats


<strong>neurotoxic</strong> <strong>cascade</strong> <strong>in</strong> <strong>the</strong> <strong>ischemic</strong> <strong>penumbra</strong><br />

De Keyser et al., 1999<br />

-Annex<strong>in</strong><br />

PLA2<br />

BBB disruption, endo<strong>the</strong>lial disturbances<br />

Cell <strong>in</strong>filtration<br />

Cell necrosis<br />

Tissue remodel<strong>in</strong>g, angiogenesis,


apoptotic cells/necrotic cells = 1:1<br />

ag<strong>in</strong>g of apoptotic cell death<br />

ll death 4h after 2h MCAO<br />

apoptotic cells/necrotic cells = 9:1<br />

Charriaut-Marlangue C. et al., JCBFM, 19<br />

Apoptosis<br />

Necrosis


ag<strong>in</strong>g of apoptotic cell death<br />

Annex<strong>in</strong> V<br />

- 36-kDa prote<strong>in</strong><br />

- high aff<strong>in</strong>ity to phosphatidylser<strong>in</strong>e at <strong>the</strong><br />

surface of apoptotic cel<br />

- detection of <strong>the</strong> earliest stages of apoptosis<br />

SPECT<br />

– 99mTc-HYNIC-annex<strong>in</strong> V<br />

(hydraz<strong>in</strong>onicot<strong>in</strong>amide<br />

derivatized annex<strong>in</strong> V)<br />

– novel form of annex<strong>in</strong> V :<br />

PET<br />

– 18F-Annex<strong>in</strong> V<br />

– 124I-annex<strong>in</strong> V


ECT imag<strong>in</strong>g <strong>in</strong> rats submitted to<br />

2 h left MCAO followed by<br />

SPECT imag<strong>in</strong>g <strong>in</strong> rabbits suffer<strong>in</strong><br />

from neonatal hypoxic bra<strong>in</strong> <strong>in</strong>jur<br />

ECT imag<strong>in</strong>g of apoptosis<br />

99mTc-HYNIC-annex<strong>in</strong> V<br />

Mari et al., Eur J Nucl Med Mol Imag<strong>in</strong>g 2004<br />

D’Arceuil et al., Stroke 2000


T imag<strong>in</strong>g of apoptosis<br />

PET annex<strong>in</strong> V<br />

Radiolabeled annex<strong>in</strong> V PET imag<strong>in</strong>g of liver apoptosis<br />

Control<br />

Cycloheximide<br />

treated rats<br />

Untreated mice<br />

anti-Fas mAb-treated<br />

mice<br />

124<br />

I- Annex<strong>in</strong> V<br />

18<br />

F- Annex<strong>in</strong> V


<strong>neurotoxic</strong> <strong>cascade</strong> <strong>in</strong> <strong>the</strong> <strong>ischemic</strong> <strong>penumbra</strong><br />

De Keyser et al., 1999<br />

11<br />

C-PJ34<br />

PLA2<br />

BBB disruption, endo<strong>the</strong>lial disturbances<br />

Cell <strong>in</strong>filtration<br />

Cell necrosis<br />

Tissue remodel<strong>in</strong>g, angiogenesis,


T imag<strong>in</strong>g of free radical-<strong>in</strong>duced necrosis<br />

11<br />

C-PJ34 : phenanthrid<strong>in</strong>one derivative which<br />

b<strong>in</strong>ds to PARP<br />

PARP-1 is up-regulated dur<strong>in</strong>g cell necrosis<br />

streptozotoc<strong>in</strong>-<strong>in</strong>duced pancreas necrosis<br />

Control<br />

No sta<strong>in</strong><strong>in</strong>g was observed <strong>in</strong> control rats.<br />

STZ treated<br />

Accumulation of 11 C-PJ34 is shown <strong>in</strong> STZtreated<br />

rats as dark brown sta<strong>in</strong><strong>in</strong>g localized<br />

<strong>in</strong> <strong>the</strong> nuclei of islets <strong>in</strong> <strong>the</strong> rat pancreas


<strong>neurotoxic</strong> <strong>cascade</strong> <strong>in</strong> <strong>the</strong> <strong>ischemic</strong> <strong>penumbra</strong><br />

De Keyser et al., 1999<br />

11<br />

C-octanoate<br />

11<br />

C-PK11195<br />

PLA2<br />

BBB disruption, endo<strong>the</strong>lial disturbances<br />

Cell <strong>in</strong>filtration<br />

Cell necrosis<br />

Tissue remodel<strong>in</strong>g, angiogenesis,


ag<strong>in</strong>g of microglia <strong>in</strong>filtration after ischemia–reperfusion<br />

RICHARD B. BANATI GLIA (2002)<br />

peripheral<br />

benzodiazep<strong>in</strong>e<br />

receptors


T Imag<strong>in</strong>g of activated microglia <strong>in</strong>filtration<br />

Sette et al. Stroke,199<br />

11<br />

C-PK11195<br />

11C-PK11195 b<strong>in</strong>d<strong>in</strong>g after focal ischemia (MCAO) <strong>in</strong> <strong>the</strong> anes<strong>the</strong>tized baboon<br />

11<br />

C-flumazenil


T imag<strong>in</strong>g of dur<strong>in</strong>g MCAO-<strong>in</strong>duced astrocytes <strong>in</strong>filtration<br />

Kuge et al., Ann.Nucl.Med, 2<br />

11<br />

C-octanoate uptake <strong>in</strong> a dog 24h after MCAO


<strong>neurotoxic</strong> <strong>cascade</strong> <strong>in</strong> <strong>the</strong> <strong>ischemic</strong> <strong>penumbra</strong><br />

Dimeric RGD peptide<br />

Monomeric RGD peptide<br />

a 5 ß 3 <strong>in</strong>tegr<strong>in</strong> receptors<br />

VEGF receptors<br />

PLA2<br />

BBB disruption, endo<strong>the</strong>lial disturbances<br />

Cell <strong>in</strong>filtration<br />

Cell necrosis<br />

Tissue remodel<strong>in</strong>g, angiogenesis,


T imag<strong>in</strong>g of <strong>in</strong>tegr<strong>in</strong> receptors<br />

18<br />

F-FB-E[c(RGDyK)]2 dimeric ligand of avß3 <strong>in</strong>tegr<strong>in</strong> receptor<br />

<strong>in</strong>oculation of U87MG human glioblastoma cells <strong>in</strong>to mouse forebrai<br />

Tumor to contralateral background ratio = 9.5 +/- 0.8<br />

Chen et al., Mol Imag<strong>in</strong>g Biol, 2006


ECT imag<strong>in</strong>g of <strong>in</strong>tegr<strong>in</strong> receptors<br />

Meoli et al., J Cl<strong>in</strong> Invest. 200<br />

111In-RP748 : qu<strong>in</strong>olone targeted at avß3 <strong>in</strong>tegr<strong>in</strong> receptor<br />

111In-RP748, a<br />

gs with chronic myocardial <strong>in</strong>farction<br />

<strong>in</strong>creased myocardial uptake (red) <strong>in</strong> <strong>the</strong><br />

region of <strong>in</strong>jury-<strong>in</strong>duced angiogenes<br />

99m<br />

Tc-MIBI<br />

111<br />

In-RP748


ag<strong>in</strong>g of VEGF receptors<br />

VEGF is an angiogenic prote<strong>in</strong> secreted <strong>in</strong> response to<br />

hypoxia that b<strong>in</strong>ds to VEGF receptors Flt-1 and KDR<br />

overexpressed by <strong>ischemic</strong> microvasculature.


ag<strong>in</strong>g of VEGF receptors<br />

111In-labeled VEGF<br />

Lu et al., Circulation 2003<br />

Ischemic h<strong>in</strong>dlimb (rabbit)<br />

111<br />

In-labeled VEGF accumulation <strong>in</strong><br />

<strong>ischemic</strong> h<strong>in</strong>dlimb<br />

124I radiolabeled mAb aga<strong>in</strong>st VEGF Coll<strong>in</strong>gridge et al., Cancer Res. 200<br />

B<strong>in</strong>ds to angiogenic areas <strong>in</strong> tumor-bear<strong>in</strong>g mice


ture directions of stroke PET and SPECT imag<strong>in</strong>g<br />

Imag<strong>in</strong>g hypoxic cells with reporter genes<br />

Acycloguanos<strong>in</strong>e Pyrimid<strong>in</strong>e derivatives<br />

HSV-tk1<br />

HIF-1


Conclusion<br />

Most promis<strong>in</strong>g PET and SPECT radiotracers for<br />

stroke : angiogenesis radiotracers developed for<br />

tumor hypoxia<br />

Transferability from tumor to bra<strong>in</strong> hypoxia :<br />

pharmacok<strong>in</strong>etic considerations<br />

PET and SPECT track<strong>in</strong>g of stem cell <strong>the</strong>rapy of<br />

stroke by reporter genes transfected <strong>in</strong>side <strong>the</strong> cells.<br />

– Neural stem cells<br />

124I<br />

– Endo<strong>the</strong>lial progenitors


Leucocytes <strong>in</strong>filtration<br />

after ischemia–reperfusion


perimental models and Animal species<br />

enetically homogeneous<br />

ophisticated neurosensory and motor behavior measurements<br />

as outcome measures of <strong>in</strong>jury from ischemia<br />

mall animals : lissencephalic bra<strong>in</strong>s<br />

Focal cerebral ischemia (transient or permanent) :<br />

non human primate, dog, cat,<br />

rabbit, gu<strong>in</strong>ea pig, rat, mouse.<br />

Global cerebral ischemia<br />

- complete (transient) :<br />

- <strong>in</strong>complete (transient or premanent) :<br />

non human primate, dog, cat, rat,<br />

mouse, gerbil, sheep<br />

dog, cat, pig, rat, mouse, gerbil,<br />

sheep.<br />

Multifocalcerebral ischemia :<br />

Rabbit, rat.<br />

Intracerebelar hemorrhage :<br />

Subarachnoid hemorrhage and vasospasm :<br />

non human primate, dog, cat, rat,<br />

pig, rabbit.<br />

non human primate, dog, cat, rat,<br />

mouse, pig, rabbit.<br />

(from Traytsman, ILAR J. 2003; Andaluz et al., Neurosurg Cl<strong>in</strong> N Am 2

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!